James S. New

Statistics

Publications

Citations

769

H-Index

Active since

1982

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Alabama at Birmingham

Bristol-Myers Squibb (Germany)

James S. New is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicinal chemistry, and antipsychotic pharmacotherapy.

Publications per year

1982–2020

Publications

Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl)- and (1,2-benzisoxazol-3-yl)piperazine derivatives as potential antipsychotic agents

Joseph P. Yevich, James S. New, David W. Smith et al. · Journal of Medicinal Chemistry · 1986 · 114 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The thieno[3,2-c]pyridine and furo[3,2-c]pyridine rings: new pharmacophores with potential antipsychotic activity

James S. New, William L. Christopher, Joseph P. Yevich et al. · Journal of Medicinal Chemistry · 1989 · 97 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Oral delivery of bioencapsulated exendin‐4 expressed in chloroplasts lowers blood glucose level in mice and stimulates insulin secretion in beta‐<scp>TC</scp>6 cells

Kwang‐Chul Kwon, Ramya Nityanandam, James S. New et al. · Plant Biotechnology Journal · 2012 · 96 citations · Full text

Pharmacy, Endocrinology, Pharmacology +16

Neonatal Exposure to Commensal-Bacteria-Derived Antigens Directs Polysaccharide-Specific B-1 B Cell Repertoire Development

James S. New, Brian Dizon, Christopher Fucile et al. · Immunity · 2020 · 86 citations · Full text

Life Sciences, Immunology, Microbiology +14

Buspirone: chemical profile of a new class of anxioselective agents.

D L Temple, Joseph P.Yevich, James S. New · PubMed · 1982 · 67 citations

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 15